Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA:600380)

SHA:600380 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14,868	14,852	15,692	14,808	11,729	12,289
Short-Term Investments	-	556.41	406.38	54.05	-	-
Trading Asset Securities	68.32	89.36	82.9	109.02	184.64	28.33
Cash & Short-Term Investments	14,936	15,498	16,181	14,972	11,914	12,317
Cash Growth	-3.51%	-4.22%	8.08%	25.66%	-3.28%	9.90%
Accounts Receivable	4,506	4,381	4,634	5,064	4,831	3,790
Other Receivables	57.91	51.17	46.01	52.54	88.05	197.17
Receivables	4,563	4,432	4,680	5,116	4,919	3,988
Inventory	2,485	2,621	2,656	2,562	2,079	1,832
Other Current Assets	1,053	454.5	357.51	527.81	453.22	268.02
Total Current Assets	23,038	23,006	23,875	23,178	19,365	18,405
Property, Plant & Equipment	6,222	6,259	6,193	6,118	5,629	5,047
Long-Term Investments	2,502	3,531	3,206	3,426	2,880	2,205
Goodwill	636.34	636.34	636.34	614.47	614.47	614.47
Other Intangible Assets	659.96	687.43	683.34	802.12	456.78	468.09
Long-Term Accounts Receivable	-	-	-	-	0.27	-
Long-Term Deferred Tax Assets	690.48	685.47	579.53	540.04	552.54	468.9
Long-Term Deferred Charges	708.03	362.7	483.49	428.28	786.99	399.12
Other Long-Term Assets	1,312	549.95	702.25	628.27	818.36	550.38
Total Assets	35,769	35,718	36,358	35,735	31,104	28,157
Accounts Payable	2,091	2,150	2,363	2,580	2,454	1,920
Accrued Expenses	194.06	3,685	3,947	4,178	3,749	3,258
Short-Term Debt	2,325	2,455	2,076	2,126	2,518	2,111
Current Portion of Long-Term Debt	435.33	376.17	696.48	43.66	70.28	-
Current Portion of Leases	-	210.34	214.93	19.42	21.3	8.54
Current Income Taxes Payable	247.6	150.51	248.97	124.04	145.11	197.93
Current Unearned Revenue	83.76	142.4	159.08	292.98	234.14	133.42
Other Current Liabilities	3,393	100.74	154.29	390.77	160.17	172.99
Total Current Liabilities	8,770	9,271	9,861	9,755	9,352	7,802
Long-Term Debt	2,538	2,425	3,122	3,231	826.78	360.32
Long-Term Leases	24.38	19.98	15.42	23.48	25.07	9.82
Long-Term Unearned Revenue	314.24	334.97	370.18	384.54	433.54	467.56
Long-Term Deferred Tax Liabilities	269.01	267.62	260.03	237.19	208.53	202.26
Other Long-Term Liabilities	-	-	90	84	78	78
Total Liabilities	11,915	12,318	13,719	13,715	10,924	8,920
Common Stock	1,829	1,874	1,866	1,929	1,908	1,953
Additional Paid-In Capital	1,056	1,175	1,352	2,222	2,153	2,531
Retained Earnings	11,811	11,376	10,301	9,192	7,864	6,747
Treasury Stock	-	-328.22	-	-347.18	-222.64	-253.64
Comprehensive Income & Other	-51.45	437.84	237.07	126.72	117.88	118.57
Total Common Equity	14,645	14,535	13,756	13,122	11,820	11,096
Minority Interest	9,209	8,865	8,884	8,898	8,359	8,141
Shareholders' Equity	23,854	23,400	22,640	22,020	20,180	19,237
Total Liabilities & Equity	35,769	35,718	36,358	35,735	31,104	28,157
Total Debt	5,322	5,486	6,125	5,443	3,462	2,490
Net Cash (Debt)	9,614	10,012	10,056	9,528	8,452	9,828
Net Cash Growth	-7.27%	-0.44%	5.54%	12.73%	-14.00%	15.25%
Net Cash Per Share	5.09	5.34	5.30	5.02	4.36	5.02
Filing Date Shares Outstanding	1,895	1,845	1,866	1,928	1,890	1,933
Total Common Shares Outstanding	1,895	1,845	1,866	1,928	1,890	1,933
Working Capital	14,268	13,735	14,014	13,423	10,013	10,602
Book Value Per Share	7.73	7.88	7.37	6.81	6.25	5.74
Tangible Book Value	13,349	13,211	12,436	11,705	10,749	10,014
Tangible Book Value Per Share	7.05	7.16	6.67	6.07	5.69	5.18
Buildings	-	4,825	4,619	4,279	3,950	-
Machinery	-	7,534	7,108	6,524	5,928	8,985
Construction In Progress	-	531.06	531.06	811.3	743	648.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.